Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

NCT00003175 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER_GOV

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer

Interventions

DRUG: fluorouracil

Sponsor

Medical Research Council